* Revvity Inc RVTY.N reported quarterly adjusted earnings
of
$1.42 per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of
$1.25. The mean expectation of nineteen analysts for the
quarter was for earnings of $1.37 per share. Wall Street
expected results to range from $1.32 to $1.39 per share.
* Revenue rose 4.8% to $729.37 million from a year ago;
analysts
expected $727.90 million.
* Revvity Inc's reported EPS for the quarter was 78 cents.
* The company reported quarterly net income of $96.65
million.
* Revvity Inc shares had risen by 13.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4% in
the last three months.
* In the last 30 days, three analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Revvity Inc is
$136.00
This summary was machine generated from LSEG data January 31 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 1.37 1.42 Beat
Sep. 30 2024 1.13 1.28 Beat
Jun. 30 2024 1.12 1.22 Beat
Mar. 31 2024 0.93 0.98 Beat